Is sofosbuvir and velpatasvir (Epclusa) included in medical insurance?
The original drug combination of Sofosbuvir and Velpatasvir (Epclusa) has been launched in China and has entered the scope of Class B medical insurance. The domestic trade name is Epclusa. The specification (400mg + 100mg) * 28 tablets per box is about 4,000 yuan. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The original drug of sofosbuvir and velpatasvir has also been launched overseas. There are also generic drugs of sofosbuvir and velpatasvir produced in other countries. The price of the specification (400mg + 100mg) * 28 tablets produced by Everest Pharmaceutical Factory in Bangladesh is about 850 yuan per box (the price may fluctuate due to the exchange rate). The generic drugs produced abroad are basically the same as the original drugs at home and abroad.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)